CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection

Hepatology

Volumn 50, Issue 3, 2009, Pages 735-742

  Li, Dongling ^a   Zheng, Linghua ^a,b   Jin, Lei ^c   Zhou, Yuesu ^c   Li, Haiying ^d   Fu, Junliang ^c   Shi, Ming ^c   Du, Peishuang ^a   Wang, Lizhong ^e   Wu, Hao ^d   Chen, Guo Yun ^e   Zheng, Pan ^e   Liu, Yang ^a,e   Wang, Fu Sheng ^a,c   Wang, Shengdian ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c BEIJING 302 HOSPITAL   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER WEIGHT; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS LOAD; ANIMAL; GENETIC POLYMORPHISM; GENETICS; LIVER; MALE; PATHOLOGY; VIROLOGY;

ANIMALS; ANTIGENS, CD24; HEPATITIS B, CHRONIC; HUMANS; LIVER; MALE; MICE; POLYMORPHISM, GENETIC;

EID: 70349238773     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23047     Document Type: Article

References (38)

1. Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis 2002;2:43-50.
2. Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005;2:50-57. (Pubitemid 40935433)
3. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-229.
4. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004;350:1118-1129. (Pubitemid 38298992)
5. Mailliard ME, Gollan JL. Emerging therapeutics for chronic hepatitis B. Annu Rev Med 2006;57:155-166.
6. Giovanna F, Bortolotti F, Francesco D. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008;48:335-352.
7. Inchauspe G, Michel ML. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses. J Viral Hepat 2007;14(Suppl 1):S97-S103.
8. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003;9:641-644.
9. Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 2007;85:16-23.
10. Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV. Immune pathogenesis of hepatocellular carcinoma. J Exp Med 1998;188:341-350.
11. Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol 2007;13:74-81.
12. Hubbe M, Altevogt P. Heat-stable antigen/CD24 on mouse T lymphocytes: evidence for a costimulatory function. Eur J Immunol 1994;24:731-737. (Pubitemid 24076642)
13. Zhou Q, Wu Y, Nielsen PJ, Liu Y. Homotypic interaction of the heat-stable antigen is not responsible for its co-stimulatory activity for T cell clonal expansion. Eur J Immunol 1997;27:2524-2528. (Pubitemid 27453839)
14. Liu Y, Jones B, Aruffo A, Sullivan KM, Linsley PS, Janeway CA Jr. Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med 1992;175:437-445.
15. De Bruijn ML, Peterson PA, Jackson MR. Induction of heat-stable antigen expression by phagocytosis is involved in in vitro activation of unprimed CTL by macrophages. J Immunol 1996;156:2686-2692.
16. Enk AH, Katz SI. Heat-stable antigen is an important costimulatory molecule on epidermal Langerhans' cells. J Immunol 1994;152:3264-3270. (Pubitemid 24098022)
17. Wang YC, Zhu L, McHugh R, Sell KW, Selvaraj P. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice. Eur J Immunol 1995;25:1163-1167.
18. Wu Y, Zhou Q, Zheng P, Liu Y. CD28-independent induction of T helper cells and immunoglobulin class switches requires costimulation by the heat-stable antigen. J Exp Med 1998;187:1151-1156. (Pubitemid 28176416)
19. Liu Y, Wenger RH, Zhao M, Nielsen PJ. Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J Exp Med 1997;185:251-262. (Pubitemid 27078282)
20. Bai XF, Li O, Zhou Q, Zhang H, Joshi PS, Wang Y, et al. CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis. J Exp Med 2004;200:447-458. (Pubitemid 39121902)
21. Chen GY, Tang J, Zheng P, Liu Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 2009;323:1722-1725.
22. Zarn JA, Jackson DG, Bell MV, Jones T, Weber E, Sheer D, et al. The small cell lung cancer antigen cluster-4 and the leukocyte antigen CD24 are allelic isoforms of the same gene (CD24) on chromosome band 6q21. Cytogenet Cell Genet 1995;70:119-125.
23. Zhou Q, Rammohan K, Lin S, Robinson N, Li O, Liu X, et al. CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc Natl Acad Sci U S A 2003;100:15041-15046. (Pubitemid 37518013)
24. Wang L, Lin S, Rammohan KW, Liu Z, Liu JQ, Liu RH, et al. A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet 2007;3:e49.
25. Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schluns K, Denkert C, et al. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 2003;9:4906-4913. (Pubitemid 37323297)
26. Kristiansen G, Denkert C, Schluns K, Dahl E, Pilarsky C, Hauptmann S. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol 2002;161:1215-1221.
27. Kristiansen G, Pilarsky C, Pervan J, Sturzebecher B, Stephan C, Jung K, et al. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 2004;58:183-192. (Pubitemid 38160906)
28. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989;59:1145-1156. (Pubitemid 20024625)
29. Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003;23:47-58.
30. Chisari FV, Pinkert CA, Milich DR, Filippi P, McLachlan A, Palmiter RD, et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985;230:1157-1160.
31. Huang LR, Hsu HC. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res 1995;55:4717-4721.
32. Su MC, Hsu C, Kao HL, Jeng YM. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Cancer Lett 2006;235:34-39.
33. Bai XF, Liu JQ, Liu X, Guo Y, Cox K, Wen J, et al. The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis. J Clin Invest 2000;105:1227-1232. (Pubitemid 30266075)
34. Gilles PN, Fey G, Chisari FV. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol 1992;66:3955-3960.
35. Nakamoto N, Kaplan DE, Coleclough J, Li Y, Valiga ME, Kaminski M, et al. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 2008;134:1927-1937, 1937.e1921-1922.
36. Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 2008;134:1938-1949, 1949.e1931-1933.
37. Ochsner SA, Strick-Marchand H, Qiu Q, Venable S, Dean A, Wilde M, et al. Transcriptional profiling of bipotential embryonic liver cells to identify liver progenitor cell surface markers. Stem Cells 2007;25:2476-2487. (Pubitemid 47582740)
38. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008;13: 153-166. (Pubitemid 351163165)